Martin D. Sass is Chairman and Chief Executive Officer of M.D. Sass, a leading independent registered investment advisory organization which manages substantial separate accounts, hedge funds and private equity funds with a team of approximately 120 people based in N.Y.C. utilizing a variety of traditional and alternative investment strategies.
Before founding M.D. Sass in 1972, Mr. Sass was President and a principal shareholder of Neuwirth Management and Research Corp., managing mutual funds, substantial separate portfolios and hedge funds. He previously founded and directed the Special Situations Division of Argus Research Corporation, which provided independent research to financial institutions.
Mr. Sass received a B.S. in Accounting from Brooklyn College and is currently a member of the Board of Trustees and Executive Committee and Chairman of the Investment Committee of the Brooklyn College Foundation. Mr. Sass also studied finance in graduate M.B.A programs at New York University and City University of New York. He is a member of the Chief Executive’s Organization, World President’s Organization and Chairman and Founder of The Sass Foundation for Medical Research.
If you are interested in learning more about TIGER 21, please complete the contact form and you will receive a copy of our most recent Asset Allocation Report.